EU AI Policy Observatory

Published document record

Multi-annual AI workplan 2023-2028

PDF source copies

These PDFs are hosted here for continued access. Each is labelled as an unmodified official PDF or a converted reading copy. They are saved copies, not a live statement of the latest law or institutional endorsement. Official source links remain below.

  • Official PDF — unmodified source copy

    If the PDF does not display in your browser, Open PDF in a new tab or download it below. Both use the copy hosted on this site.

    Download PDF — 13 pages (0.53 MB)

    Multi-annual AI workplan 2023-2028. Version 1 - November 2023.

    Source: European Medicines Agency. Retrieved 2026-09-10.

    Copy provenance and reuse

    Unmodified source PDF. Source attribution and original notices are retained; see the source reuse terms. Source reuse terms. The database metadata licence does not replace these terms.

    SHA-256: a78324e56c93dc478d8abb5f8924c81c1cae53bc2ac4bcf27c38746b5f2242c9

Official metadata

Official title
Multi-annual AI workplan 2023-2028
Document type
Work programme
Document date
2023-12-18
Document date kind
Publication
Document-date evidence
European Medicines Agency · EMA news HTML: document First published 18/12/2023; article published_time 2023-12-18T13:59:00+0100; visible heading 18 December 2023. — Exact official publication is the fallback document date; no exact independent issue day established.
Publication date
2023-12-18
Publication-date evidence
European Medicines Agency · Live English HTML: workplan First published 18/12/2023; news published_time 2023-12-18; summary jointly credits EMA and HMA. — Establishes official publication of this version on 2023-12-18, before the 4 September 2026 cutoff.
Additional official dates
  • Cover issue: 2023-11 (month) · European Medicines Agency · PDF p. 1, cover: Multi-annual AI workplan 2023-2028, HMA-EMA Big Data Steering Group, Version 1 - November 2023. Supports month precision only.
  • Institutional adoption: 2023-12 (month) · European Medicines Agency · News body: EMA Management Board adopted at December meeting.
Version label
Version 1 - November 2023
Legal status
Non binding
Legal-status evidence
European Medicines Agency · PDF cover and p.3 Introduction; pp.5-8 workstreams on AI policy, regulatory tools, training and experimentation. — Non-legislative report, scientific guidance, strategic workplan or consultation text; not an act creating binding law.
Language
en

Research classifications

These are researcher classifications used to organise and analyse the corpus; they are not official EU metadata.

Record level
Principal
Version status
Final
Temporal collection
Contemporary EU AI policy
Relevance class
Direct AI relevance
Policy stage
Coordination
Corpus tier
Directly related
Sectors
  • Health
  • Public administration
Policy membership
  • EU AI policy pathway

Classification evidence

  • Relevance class: Direct AI relevance · European Medicines Agency · PDF cover and p.3 Introduction; pp.5-8 workstreams on AI policy, regulatory tools, training and experimentation. — AI/ML is a substantive regulatory or sectoral subject.
  • Sector tags: Health · European Medicines Agency · PDF cover and p.3 Introduction; pp.5-8 workstreams on AI policy, regulatory tools, training and experimentation. — Addresses medicines or health-insurance AI.
  • Sector tags: Public administration · European Medicines Agency · PDF cover and p.3 Introduction; pp.5-8 workstreams on AI policy, regulatory tools, training and experimentation. — Addresses regulators' own use and governance of AI tools.
  • Provenance tags: Authored by an EU agency or body · European Medicines Agency · PDF cover and p.3 Introduction; pp.5-8 workstreams on AI policy, regulatory tools, training and experimentation. — Produced within the named EU agency/body; named personal author credits remain separate.
  • Provenance tags: Joint institutional · European Medicines Agency · Publication credits: HMA-EMA joint network or EMA and HMA joint publication. — Evidence identifies joint network preparation or publication; HMA is a national-authorities network.
  • Provenance tags: Officially published · European Medicines Agency · Official record with linked English document. — Official EU endpoint distributes this independently citable English text.

Production provenance

Provenance tags
  • Authored by an EU agency or body
  • Joint institutional
  • Officially published
Named bibliographic authors
Institutions and roles

Official sources and identifiers

Research assessment

Inclusion rationale
Joint multi-year operational AI policy for the European medicines regulatory network, distinct from the later NDSG 2026-2028 workplan already in the known backlog.
Researcher notes
Cover issue has month precision. December 2023 adoption is preserved at month precision; a planned 14 December meeting is not proof of an actual adoption day. Hosted file updated 25 January 2024 still identifies Version 1, November 2023. HMA is a national-authorities network.
Review status
verified

Relationships

No additional published relationships touch this record.

Verification

Expanded evidence review
Verified
Reviewed by
Yichen Hao
Evidence review date
2026-09-05T23:48:11Z

The evidence review date is not a separate human sign-off date. Review credit and evidence-review actions

  • Last verified: 2026-09-05T23:48:11Z · EMA news HTML: document First published 18/12/2023; article published_time 2023-12-18T13:59:00+0100; visible heading 18 December 2023. Official linked English manifestation reviewed.
  • Last verified: 2026-09-05T23:48:11Z · PDF cover and p.3 Introduction; pp.5-8 workstreams on AI policy, regulatory tools, training and experimentation. English text inspected in web extraction or Node fetch plus pypdf; no retained file snapshot claimed.

Return to the Corpus